Skip to main content

New Steps Aimed at Cutting Risks from Acetaminophen

On this page

The Food and Drug Administration (FDA) has taken new steps to reduce the risk of severe liver injury associated with acetaminophen, a widely used pain- and fever-reducing drug.

On Jan. 13, 2011, FDA announced it is

In addition, FDA is requiring a Warning on labels of all prescription products that contain acetaminophen that highlights the potential for allergic reactions. These allergic reactions include swelling of the face, mouth, and throat; difficulty breathing; itching; and rash.

Used effectively in both prescription and over-the-counter (OTC) products, acetaminophen is among the most commonly used drugs in the United States.

Also called APAP, acetaminophen is used in many prescription products in combination with other drugs, usually opioids such as codeine (Tylenol with Codeine), oxycodone (Percocet), and hydrocodone (Vicodin).

back to top

Reports of Severe Liver Injury

FDA continues to receive reports of severe liver injury associated with the use of products that contain acetaminophen.

Sandra Kweder, M.D., deputy director of FDA's Office of New Drugs, says the agency's most recent action is aimed at making pain medications containing acetaminophen safer for patients to use. 

“Overdoses from prescription products containing acetaminophen account for nearly half of all cases of acetaminophen-related liver failure in the U.S., many of which result in liver transplant or death," says Kweder.

Most of the cases of severe liver injury occurred in patients who

“There is no immediate danger to patients who take these combination pain medications and they should continue to take them as directed by their health care provider,” says Kweder. "The risk of liver injury primarily occurs when patients take multiple products containing acetaminophen at one time and exceed the current maximum dose of 4,000 milligrams within a 24-hour period.”

back to top

OTC Products Already Require Warnings

Over-the-counter pain and fever medications, such as Tylenol, that contain acetaminophen are already required to change the dosage labeling to include information about the potential for safety risks, including liver injury.

In addition, FDA continues to evaluate ways to reduce the risk of acetaminophen-related liver injury from OTC products.

In its January 2011 announcement, FDA emphasized that combination products that contain 325 milligrams of acetaminophen (or less) per dosage unit are effective for treating pain.

The new dosage limit will not affect other aspects of prescribing acetaminophen combination products. The number of tablets, capsules, or other dosage units that may be prescribed and the time intervals at which they may be prescribed will not change.

In addition, the new action will be phased in over three years. Prescription pain medications containing acetaminophen will continue to be available during the transition.

back to top

Steps You Can Take

Do not stop taking your prescription pain medicine unless told to do so by your health care professional.

FDA says you can help reduce the risk of adverse effects from acetaminophen by

In addition, you can report any side effects from the use of products containing acetaminophen to FDA’s MedWatch Adverse Event Reporting Program online or by mail, fax, or phone.

This article appears on FDA's Consumer Updates page, which features the latest on all FDA-regulated products.

Posted Jan. 13, 2011

back to top

Return to FDA Consumer Articles

For more information about food, medicine, cosmetic safety and other topics for your health, visit FDA.gov/consumers.